News: Press Releases

Press Releases
Kane Biotech Announces Closing of Private Placement Offering and Issuance of Common Shares in Payment of Outstanding Interest

WINNIPEG, Manitoba – June 29, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) today announced that the Corporation has closed its previously announced private placement offering (the “Offering”) of common shares (“Common Shares”) at a price of…

> Read More

Press Releases
Kane Biotech Announces Grant of Options

Kane Biotech Announces Grant of Options

WINNIPEG, Manitoba – June 21, 2016 – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that the…

> Read More

Press Releases
Kane Biotech Announces Board Members

Kane Biotech Announces Board Members

WINNIPEG, Manitoba – June 6, 2016 – Kane Biotech Inc. (TSX-V:KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms is pleased to announce that at the…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering and Proposed Consolidation of Shares

WINNIPEG, Manitoba – June 3, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 50,000,000 common shares (“Common Shares”)…

> Read More

Press Releases
Kane Biotech Announces Insider Participation in Rights Offering

WINNIPEG, Manitoba – May 4, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce additional information regarding the participation of the insiders of the Company in the rights offering (the “Rights Offering”) of the…

> Read More

Press Releases
Kane Biotech Announces Rights Offering Closing

WINNIPEG, Manitoba – May 4, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce the closing of its rights offering (the “Rights Offering”) originally announced on March 29, 2016.

Upon closing of the Rights…

> Read More

Press Releases
Kane Biotech Announces Rights Offering

WINNIPEG, Manitoba – March 29, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it will be offering rights (“Rights”) to holders (“Shareholders”) of its common shares (“Common Shares”) of record as at 5:00 p.m.…

> Read More

Press Releases
Kane Biotech Expanding bluestem™ to the USA

WINNIPEG, Manitoba – March 1, 2016 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce it will be launching its bluestem™ brand of premium pet oral care products at Global Pet Expo in Orlando Florida…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering

WINNIPEG, Manitoba –(Marketwired – January 27, 2016) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 66,666,667 units (“Units”) at…

> Read More

Press Releases
Kane Biotech receives $240,000 from Warrant Exercise

WINNIPEG, Manitoba –(Marketwired – January 08, 2016) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation”) announced that between December 30, 2015 and January 4, 2016 it received $240,000 from the exercising of 4,000,000 warrants at $.06 per share. The warrants were…

> Read More